Obesity and type 2 diabetes (T2D) are associated with altered secretion of enteroendocrine hormones, including the glucagon-like peptide-1 (GLP-1). The mechanisms underlying this dysregulation remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results